ClinicalTrials.gov
public full text
Public Domain
Nebivolol and the Endothelin (ET)-1 System
The investigators hypothesize that nebivolol will reduce ET-1-mediated vasoconstrictor tone in adult humans with elevated blood pressure to a greater extent than either metoprolol or placebo.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Comparing the Effects of Two Beta Blockers,Metoprolol and Nebivolol,on Ambulatory Blood Pressure and Basal Metabolic Rate#623575
- Nebivolol Versus Metoprolol: Comparative Effects on Fatigue and Quality of Life#1030580
- Assessing Alternative Approaches for Blood Pressure Control: A3BC Trial#356576
- Economic Impact of Switching From Metoprolol to Nebivolol for Hypertension Treatment#833282
- Comparative Study of the Effects of Telmisartan and Nebivolol#846628
Record · ID 1137901
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive